Ingredients & evidence: 2-DDR scalp serum

2-Deoxy-D-ribose is a deoxy sugar studied primarily in wound-healing and angiogenesis contexts in preclinical models. A published alginate hydrogel study containing 2-deoxy-D-ribose is the main reference that informed the delivery system chosen for this serum.

Human cosmetic data specifically for scalp appearance at the concentration used here remain limited. The decision to center the product on this molecule rests on the available preclinical work, the ability to formulate it stably in an alginate matrix, and the absence of strong safety signals at cosmetic use levels.

Evidence character: Preclinical and mechanistic with limited direct human cosmetic trials for hair appearance. The alginate sustained-release format is taken from the published gel work rather than invented.

Niacinamide (vitamin B3) is one of the better-studied cosmetic ingredients for skin barrier support, appearance of redness, and general skin conditioning. It is widely used in leave-on facial and scalp products at concentrations typically between 2–5%.

Evidence character: Multiple human cosmetic studies exist for skin appearance and barrier function. Direct large-scale trials specifically for scalp thinning appearance are fewer, but the ingredient has a long history of cosmetic use at the level chosen.

Topical caffeine appears frequently in cosmetic scalp products. There are human studies examining its effects on the appearance of hair and scalp, as well as a substantial body of in-vitro and ex-vivo work. The 1.5% level is used here in combination with adenosine at the Japanese quasi-drug standard concentration of 0.75%.

Evidence character: Human cosmetic data exist alongside laboratory work. It is one of the more commonly studied actives in the scalp-care category. The pairing with 0.75% adenosine follows published cosmetic study concentrations.

Panthenol (pro-vitamin B5) is a classic humectant and conditioning agent used across hair and skin care. It improves the feel and manageability of hair and supports skin moisture appearance.

Evidence character: Long history of safe cosmetic use and multiple studies supporting conditioning and moisturization benefits. Positioned here as a meaningful supporting ingredient rather than a primary active for thinning appearance.

Adenosine is used at 0.75% — the concentration established as the Japanese quasi-drug standard for hair-care products. The mechanism is receptor-mediated. Once the receptors are saturated, higher concentrations do not produce additional activity. The dose was therefore set to the evidence rather than rounded upward for a stronger-looking label claim.

Evidence character: Supported by regulatory acceptance and defined use levels in a major market, plus laboratory research on receptor activity. The decision to stay at 0.75% rather than increase the percentage is deliberate.

Used at 0.1%, matching the concentration in the published double-blind, placebo-controlled trial (Fischer et al., 2004). Evidence is real but modest — the androgenetic alopecia subgroup was small, and the significant effect reported was in occipital hair.

Melatonin has also been examined for antioxidant and cosmetic scalp-appearance endpoints in later work. It remains a supporting active rather than a primary driver of the formula.

Evidence character: Human RCT data exist at this concentration. Results should be read carefully: modest effect size, limited AGA subgroup, regional (occipital) finding.

Sodium alginate creates the sustained-release character of the serum. The published research that supports the use of 2-deoxy-D-ribose employed an alginate sustained-release hydrogel. This product uses the same matrix approach. The delivery system was chosen to match the form studied, rather than placing the active in a simple fast-release vehicle.

The matrix is deliberately kept clean. No sodium chloride, zinc salts, or copper salts are added. Divalent cations crosslink alginate in an uncontrolled way and change the gel structure. A chelator (sodium phytate) is included specifically to sequester stray calcium and magnesium from the water phase so the matrix can form as intended.

The exact percentage is still being finalized at the bench so that texture, film formation, and wash-off behavior are practical for daily scalp use. The matrix is a delivery choice, not an “active” in the same sense as the molecules listed above.

Sodium phytate (inositol hexaphosphate) is present at a low level but performs three distinct jobs:

• Matrix protection — chelates residual calcium and magnesium so they cannot crosslink the alginate.
• Preservative potentiation — supports the overall preservation system.
• Anti-glycation activity — documented metal-ion chelation that interrupts metal-catalysed stages of advanced glycation end-product formation. Human data exist for oral phytate lowering circulating AGEs; the same chemical mechanism is relevant topically.

This matters because 2-deoxy-D-ribose is a reducing sugar, and pentoses are among the most glycation-reactive sugars. The formula therefore pairs the most reactive sugar class with a metal chelator plus antioxidant support (niacinamide and melatonin), covering the three recognised anti-glycation routes: metal chelation, reactive-carbonyl handling, and free-radical scavenging.

Formulation note: Phytate is treated as a high-value multi-function ingredient and is not reduced or removed.

Ethylhexylglycerin is included at 0.10% as a preservative synergist in the ratio used by validated phenoxyethanol systems (approximately 90:10 phenoxyethanol to ethylhexylglycerin). At this level it supports the primary preservative by improving its effectiveness at the microbial membrane.

The concentration is deliberately kept at the validated ratio rather than elevated. Higher levels increase allergen exposure and solubility pressure without additional validated benefit in this system.

Formulation note: It is nonionic, chemically stable with the other ingredients in the formula, and enters after the alginate gel has formed.